Top Story

Elotuzumab plus stem cell transplant shows promise for multiple myeloma

February 22, 2018
Meeting News

Early HSCT prolongs PFS, not OS, for multiple myeloma

February 21, 2018
SALT LAKE CITY — Upfront high-dose chemotherapy with early autologous hematopoietic stem cell transplantation prolonged PFS compared with standard-dose…
In the Journals Plus

Study identifies racial disparities in multiple myeloma treatment, outcomes

February 20, 2018
Outcomes for patients with multiple myeloma treatment appeared to substantially improve in recent years, according to findings published in Cancer. However, racial…
Meeting NewsPerspective

Racial disparities persist in stem cell transplant for multiple myeloma

February 19, 2018
ATLANTA — More non-Hispanic whites underwent hematopoietic stem cell transplant for initial therapy for multiple myeloma compared with non-Hispanic blacks…
More Headlines »

EGFR-mutated NSCLC: Differentiating Options to Optimize Patient Care

This educational activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Lung cancer is the second most commonly diagnosed cancer within the United States and accounts for approximately 25% of…
More »

Baseball star who survived melanoma ‘suffering’ from lack of sunscreen use

September 22, 2017
More »
Resource Centers
BMT Tandem Meetings

BMT Tandem Meetings


Addressing Common Patient Concerns Regarding Biosimilars

This activity is supported by an educational grant from Pfizer, Inc.

As more biosimilars are approved for use in the United States, greater emphasis is needed on educating patients about…
More »